Detalles de la búsqueda
1.
Intensive first-line FIr-C/FOx-C association of triplet chemotherapy plus cetuximab in RAS wild-type metastatic colorectal cancer patients: preliminary phase II data and prediction of individual limiting toxicity syndromes by pharmacogenomic biomarkers.
Ther Adv Med Oncol
; 11: 1758835919846421, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31205502
2.
Dose-finding study of intensive weekly alternating schedule of docetaxel, 5-fluorouracil, and oxaliplatin, FD/FOx regimen, in metastatic gastric cancer.
Oncotarget
; 9(29): 20339-20350, 2018 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755655
3.
Real life triplet FIr/FOx chemotherapy in first-line metastatic pancreatic ductal adenocarcinoma patients: recommended schedule for expected activity and safety and phase II study.
Oncotarget
; 9(61): 31861-31876, 2018 Aug 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30159128
Resultados
1 -
3
de 3
1
Próxima >
>>